Platinum Industries Limited announced its unaudited financial results for the quarter ended December 31, 2025, during its board meeting held on February 12, 2026. The company reported a consolidated revenue from operations of ₹1,046.68 million for the current quarter. Alongside these results, the Board approved the incorporation of a new subsidiary, Rivadu Lifesciences Private Limited, to venture into the pharma and life sciences industry. The meeting also addressed a fire incident at its Palghar factory, for which a loss of ₹103.35 million was recognized, partially offset by an insurance claim.

The financial performance for Q3 FY2026 demonstrates steady growth in revenue and profitability. Revenue from operations increased by 6.40% on a quarter-on-quarter (QoQ) basis and 11.99% on a year-on-year (YoY) basis. Net profit for the period stood at ₹123.28 million, reflecting a significant 12.25% increase from the previous quarter, despite the challenges posed by exceptional items related to the fire incident. The following table provides a detailed comparative analysis of the consolidated financial results:

Platinum Industries Limited is a prominent player in the specialty chemicals sector, primarily focused on manufacturing PVC stabilizers, CPVC additives, and lubricants. Throughout 2025, the company has actively expanded its global footprint, notably through its subsidiary Platinum Stabilizers Egypt LLC, which is setting up a manufacturing facility in the Suez Governorate, Egypt. This expansion is part of a broader strategy to utilize IPO proceeds for capital expenditure and working capital needs. Additionally, the recent move to incorporate Rivadu Lifesciences Private Limited signifies a strategic diversification into the high-growth pharmaceutical intermediates and active pharmaceutical ingredients (API) market. The company continues to maintain a strong market position despite temporary operational disruptions at its Palghar facility.